Deep Track Capital »

Engene Holdings shares owned by Deep Track Capital

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $38M 2.3M 16.95

More positions owned by Deep Track Capital

Springworks Therapeutics (SWTX)
Amgen (AMGN)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Dyne Therapeutics (DYN)
Alnylam Pharmaceuticals (ALNY)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Intra Cellular Therapies Put Option (ITCI)
Intellia Therapeutics (NTLA)
Ocular Therapeutix (OCUL)
Dynavax Technologies Corp Com New (DVAX)
Axsome Therapeutics (AXSM)
Geron Corporation (GERN)
Autolus Therapeutics Spon Ads (AUTL)

View all positions for Deep Track Capital

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
VR Adviser
Blue Owl Capital Holdings
BVF
Deep Track Capital
Commodore Capital
Adage Capital Partners GP
Omega Fund Management
Cormorant Asset Management
Henderson Group
Perceptive Advisors
Citadel Advisors
Deerfield Management Company
Logos Global Management
Soleus Capital Management

View all funds holding Engene Holdings